Axogen prices $208.7 million stock offering at $42.50 per share

Alachua and Tampa, Florida - Axogen Inc. has announced the pricing of a public offering of 4.91 million shares of common stock at $42.50 per share, according to a press release. The company has given underwriters the option to buy up to an additional 736,500 shares at the same price. Assuming no extra shares are purchased, Axogen anticipates raising approximately $208.7 million in gross proceeds, which will be used to fund the acquisition of BioCircuit Technologies Inc. and cover related fees and expenses.

The offering, which is not dependent on the BioCircuit acquisition closing, is being made under a shelf registration statement filed with the SEC on January 21, 2026. Axogen specializes in surgical solutions for restoring peripheral nerve function, with products including nerve allografts, connectors, protectors, and tissue matrix products.